penny stock exchange

On Tuesday, our Under the Radar Moversnewsletter suggested shorting small cap footwear retailer DSW Inc (NYSE: DSW):

The chart speaks for itself. DSW is making lower lows this month after failing to cross back above the 100-day and 200-day moving average lines (gray and green) last month. What you can’t quite see on our close-up chart is that DSW has been in a downtrend since 2014, and it doesn’t appear to be letting up.

Our Under the Radar Moversnewsletterwould have a further discussion about DSW Incs technical chart along with a shorting strategy:

Small cap DSW Inc is a leading branded shoes and accessories retailer that offers a wide selection of brand name and designer shoes and accessories for women, men, and kids. As of March 23, 2017, Designer Shoe Warehouse operates 504 stores in 43 states and operates an e-commerce site, www.dsw.com, and a mobile website, m.dsw.com. DSW Inc also supplies footwear to 393 leased locations in the United States.

penny stock exchange: FXCM Inc.(FXCM)

Advisors’ Opinion:

  • [By Lisa Levin]

    FXCM Inc (NASDAQ: FXCM) shares dropped 53 percent to $3.24 after the company announced regulatory settlements with NFA and CFTC against its U.S. subsidiary, Forex Capital Markets LLC. Gain Capital Holdings Inc (NYSE: GCAP) agreed to acquire the client base of FXCM's U.S. operations after FXCM reported that it will be withdrawing from U.S. business.

penny stock exchange: Cott Corporation(COT)

Advisors’ Opinion:

  • [By Dan Moskowitz]

    Cott (NYSE: COT  ) produces and sells over 200 different types of beverages in over 50 countries, and it implements a highly effective strategy. Cott is what is known as a Fast Follower, which makes it unique to other beverage companies.

penny stock exchange: Phillips 66(PSX)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    After facing several challenges last year, Phillips 66 (NYSE:PSX) enjoyed a bit of a bounce back in the first quarter. The refiner delivered expectation-smashing results, reporting an adjusted profit of $294 million, or $0.56 per share, which was a remarkable $0.51 per share ahead of the consensus estimate. Fueling the quarter were robust chemicals results and improving midstream earnings, which more than overcame continued weakness in the refining segment.

  • [By Paul Ausick]

    Phillips 66 (NYSE: PSX) said on Saturday that its operated Pasadena refined products terminal resumed truck loading and diesel loading is set to begin Sunday. Activities at the Mont Belvieu fractionator has been suspended due to a lack of available storage at the Mont Belvieu hub. The company is checking its Sweeny refinery (247,000 barrels a day) for damage and making repairs before resuming operations.

  • [By Matthew DiLallo]

    After facing several challenges in 2016 that pushed down results, Phillips 66 (NYSE:PSX) bounced back big-time in the first quarter. The company trounced the consensus estimate by a whopping $0.51 per share, which was roughly 10 times higher than the $0.05 per share analysts expected.

penny stock exchange: Randgold Resources Limited(GOLD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Gold mining stocks were also lower, with Randgold Resources (GOLD) falling around 1.5% and Fresnillo Plc (FNLPF) slipping 0.85%. Randgold’s 10.66% advance over the past three months, however, has nearly doubled that of spot gold prices while Fresnillo’s 15.82% rise is nearly three times higher than the bullion’s gain over the same period. 

  • [By Alex McGuire]

    This list shows the top-performing gold stocks this month, which we’ll be watching in September 2017. While these stocks posted gains in August, we still aren’t recommending them. Instead, we’re going to show you Money Morning Resource Specialist Peter Krauth’s pick for the best gold stock to buy this year…

    Top Gold Stock Share Price August 2017 Gain
    Sibanye Gold Ltd. (NYSE ADR: SBGL) $6.35 +22.9%
    Iamgold Corp. (NYSE: IAG) $6.49 +20%
    Alamos Gold Inc. (NYSE: AGI) $8.17 +15.1%
    Franco Nevada Corp. (NYSE: FNV) $81.20 +11.6%
    Hudbay Minerals Inc. (NYSE: HBM) $8.70 +11.5%
    Gold Fields Ltd. (NYSE ADR: GFI) $4.42 +10.9%
    Randgold Resources Ltd. (Nasdaq ADR: GOLD) $101.90 +9.6%
    Harmony Gold Mining Co. (NYSE ADR: HMY) $1.97 +8.8%
    Agnico Eagle Mines Ltd. (NYSE: AEM) $50.60 +8.4%
    Yamana Gold Inc. (NYSE: AUY) $2.81 +7.9%

    Life-Changing Profits: This investing strategy has racked up 30 triple-digit wins so far this year – and 46 in the last 12 months. To learn how to get in position for the next one, click here now…

  • [By WWW.THESTREET.COM]

    Seabridge Gold (SA) : “I like profitable gold companies like Randgold Resources (GOLD) and Kirkland Lake (KL) .”

    Impinj (PI) : “That’s a crowded market, you need to be careful.”

  • [By SEEKINGALPHA.COM]

    Thus we are still extremely cautious in gold as we are a bit worried about next week’s job report being positive and knocking gold down, but we maintain our core positions in gold. But we aren’t looking to re-establish any of our sold gold and silver positions just yet until we see more of a pullback in the metals or a bad jobs report and thus we think investors should hold off or lighten up on gold positions in the ETF’s and miners such as the SPDR Gold Trust ETF (NYSEARCA:GLD), ETFS Physical Swiss Gold Trust ETF (NYSEARCA:SGOL), iShares Silver Trust (NYSEARCA:SLV), and miners such as Randgold (GOLD) and Barrick Gold (NYSE:ABX).

penny stock exchange: Portola Pharmaceuticals, Inc.(PTLA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares dropped 23 percent to $21.92 after announcing Phase III Betrixaban results.

    Shares of Spark Energy Inc (NASDAQ: SPKE) were down 16 percent to $20.43. Spark Energy reported Q4 GAAP EPS of $(0.01) and adjusted EBITDA of $16.3 million.

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares dropped 30 percent to $20.08 after announcing Phase III Betrixaban results.

    Shares of Spark Energy Inc (NASDAQ: SPKE) were down 14 percent to $20.96. Spark Energy reported Q4 GAAP EPS of $(0.01) and adjusted EBITDA of $16.3 million.

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares were also up, gaining 46 percent to $55.68 after the company disclosed that the FDA has approved Bevyxxa, a blood-thinner for acutely ill patients not undergoing surgery. BevyxXa is the first oral drug of its kind to be approved to help prevent deep vein thrombosis and pulmonary embolisms..

Leave a Reply

Your email address will not be published. Required fields are marked *